When: Confirmed daily close above $107-108 (10 EMA) with RSI above 50

Then: Deploy 30% of incremental position

When: Flush to $96-100 zone with capitulation characteristics (RSI <28, volume spike, Bollinger lower band pierce)

Then: Deploy 30% of incremental position for bear-case entry

When: Q3 2026 earnings beat with EPS expansion toward $1.30+ quarterly (annualized $5.20+) and Medical Devices margin recovery to 15%+

Then: Deploy 30% of incremental position for earnings-validation entry

When: Weekly close below $100

Then: Trim to Underweight (50% position reduction)

HOLD with tiered accumulation; adjust stop loss to hard (non-negotiable) trigger at weekly close below $100

• Bollinger lower band pierce + RSI toward 30 historically marks short-term bottoms BUT also appears at the START of multi-week declines — cannot distinguish in real time; buying at first lower band tag in early May 2025 caught another 15 to 20 percent downside before actual bottom
• Tiered accumulation mathematically limits cost basis risk; if ABT flushes to $94-96, average entry is materially better than all-in at $103.36; if correct, still owns meaningful size at defensible price
• $94-96 flush would be gift-wrapped entry: Dividend Aristocrat with 54 consecutive years of increases, $7 billion in FCF, 15x forward earnings, defensive franchise with beta under 0.6
• Balance sheet structural transformation in 90 days: long-term debt up 143 percent, total assets jumped 27 percent, goodwill ballooned to $35 billion (48 percent of total assets); goodwill-quality of credit is the equity-side impairment risk if synergies don't materialize
• Defensive outperformance in macro stress (surging yields, hot PPI, oil shock, no Fed cuts) means relative resilience, not absolute upside; rotation is slow shift in flows over weeks and months, not single event requiring immediate deployment
• Fresh MACD cross below signal line with histogram at minus 1.57 and expanding, no bullish RSI divergence, price below all three major moving averages = confirmed short-term downtrend, not momentum reset
• Forward EPS of $6.06 versus TTM of $3.09 is 96 percent expansion dependent on integration synergies, margin recovery, tax normalization, AND execution; if two components underperform 10 percent, forward EPS closer to $5.30, price closer to $90 at 17x multiple

→ vs aggressive: Capitulation thesis pattern (Bollinger lower band, RSI toward 30) is real but treacherous to time; aggressive all-in at $103.36 before confirmation, before clean reclaim of 10 EMA, before RSI bullish divergence, before earnings validation of $6.06 forward = premature deployment into uncertain inflection point

→ vs aggressive: $94-96 flush being 'thesis broken, falling knife' is backwards; broken-thesis flushes are exactly when you get best risk-adjusted entries; pre-commit to buying the flush zone BECAUSE thesis is under stress, not in spite of it

→ vs aggressive: TTM P/E of 33x versus forward of 17x is market pricing in impairment risk from goodwill quality; equity-side impairment risk is real and requires conservative positioning, not aggressive buying

→ vs aggressive: MACD bearish cross described as 'momentum reset' is narrative not quantified; confirmed downtrend requires waiting for chart confirmation of change, not assuming change based on historical analogy

→ vs aggressive: Forward EPS of $6.06 modeled as certainty ignores probability that integration synergies, margin recovery, tax normalization, and execution could underdeliver; aggressive analyst treating bull case as base case when risk management requires sizing for underperformance scenarios

HOLD with modified 40-30-30 tiered accumulation plan; deploy 40% on $103 defense with RSI above 32, 30% on $107-108 reclaim with RSI above 50, reserve 30% for $96-100 downside or Q3 earnings; hard stop at $100 weekly close.

• First tranche trigger should be simpler: successful defense of $103 zone with daily close above lower Bollinger band ($103.66) and RSI holding above 32 within 3-5 sessions, not requiring full reversal confirmation
• Flip tier sizing from 25-25-50 to 40-30-30 or 50-25-25; first tranche should be largest for cheapest entry during early recovery
• Hard stop at $100 weekly close is non-negotiable; immediate trim on breach
• Use 2.39% dividend yield (54-year growth history) as structural anchor; 0.06% per week dividend reduces cost of holding patience
• Market is appropriately cautious at 17x forward P/E due to integration uncertainty; not the 22-25x typical for this dividend track record
• Goodwill impairment risk is real but bounded by the $100 stop; should not prevent sensible entry today
• Credit narrative is manageable (FCF coverage) but equity integration risks are unproven, justifying market's caution

→ vs aggressive: Capitulation framing has selection bias; lower band tags that preceded multi-week declines are forgotten; May 2025 bottom took weeks and multiple tags to form, so deploying meaningful capital at first signal is pattern-matching impatience, not conviction

→ vs aggressive: Dismissal of $94-96 flush as thesis-broken is intellectually lazy; at 15x forward multiple with $7B FCF, beta under 0.6, and 2.39% yield, that zone is a gift-wrapped entry

→ vs aggressive: Binary thesis framework (bounce now or thesis dead) misses that theses get stressed before breaking; best entries happen in stress zones

→ vs aggressive: Credit narrative is not overstated; FCF coverage makes debt surge manageable, but equity-side risks around goodwill quality and integration delays are real

→ vs conservative: Reserving 50% for Q3 2026 is overweighting back end; if TactiFlex Duo catalyst and macro defensive rotation play out, ABT could reach $112-115 before Q3, leaving conservative plan deploying at worst levels

→ vs conservative: Philosophical dodge: 'not paid to be right about direction, paid to be right about risk-adjusted returns' conflates prudent risk management with risk avoidance; you don't have to abstain from positive expected value setups

→ vs conservative: Overcomplicating defensive relative vs absolute performance argument; practically irrelevant for the decision to add or hold at $103.36

→ vs conservative: Goodwill impairment tail risk is real but overweighted; typically manifests in 12-24 months, and $100 stop bounds this risk for current tactical decision